Krishna, S
(2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against.
Malar J, 18 (1).
p. 339.
ISSN 1475-2875
https://doi.org/10.1186/s12936-019-2976-7
SGUL Authors: Krishna, Sanjeev
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (786kB) | Preview |
Abstract
Managing multidrug resistant malaria can be problematic if currently available artemisinin-containing anti-malarial combination treatments are not used appropriately. Here, I debate that the best way to manage multidrug resistant malaria is to make best use of existing treatments and to develop new classes of anti-malarial drugs and not to make 'triple combination therapies' when there is already resistance to one or more proposed components.
Item Type: | Article |
---|---|
Additional Information: | © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | 1108 Medical Microbiology, Tropical Medicine |
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: | Malar J |
ISSN: | 1475-2875 |
Language: | eng |
Publisher License: | Creative Commons: Attribution 4.0 |
PubMed ID: | 31581951 |
Go to PubMed abstract | |
URI: | https://openaccess.sgul.ac.uk/id/eprint/111263 |
Publisher's version: | https://doi.org/10.1186/s12936-019-2976-7 |
Statistics
Actions (login required)
![]() |
Edit Item |